Skip to main content
SpringerLink
Log in

Other Neoplasms

  • Chapter
Clinical Nuclear Medicine in Pediatrics

  • 1106 Accesses

Abstract

This chapter focuses on four relatively rare cancers in pediatrics. These neoplasms include hepatoblastoma, desmoplastic small-round-cell tumor, Langerhans cell histiocytosis, and adrenocortical carcinoma. We review the literature on the use of scintigraphy and other correlative imaging in these cancers and present clinical case examples for each condition.

Financial Disclosures: None

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Roebuck DJ, Perilongo G (2006) Hepatoblastoma: an oncological review. Pediatr Radiol 36:183–186

    Article  PubMed  Google Scholar 

  2. Czauderna P, Lopez-Terrada D, Hiyama E et al (2014) Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy. Curr Opin Pediatr 26:19–28

    Article  CAS  PubMed  Google Scholar 

  3. Meyers RL, Tiao G, de Ville de Goyet J et al (2014) Hepatoblastoma state of the art: pre-treatment extent of disease, surgical resection guidelines and the role of liver transplantation. Curr Opin Pediatr 26:29–36

    Article  CAS  PubMed  Google Scholar 

  4. Wang YX, Liu H (2012) Adult hepatoblastoma: systemic review of the English literature. Dig Surg 29:323–330

    Article  CAS  PubMed  Google Scholar 

  5. Hishiki T (2013) Current therapeutic strategies for childhood hepatic tumors: surgical and interventional treatments for hepatoblastoma. Int J Clin Oncol 18:962–968

    Article  CAS  PubMed  Google Scholar 

  6. Seitz G, Fuchs J, Schaaefer JF et al (2012) Molecular imaging and photodynamic therapy in hepatoblastoma. Front Biosci (Elite Ed) 4:487–492

    Article  Google Scholar 

  7. Watanabe K (2013) Current chemotherapeutic approaches for hepatoblastoma. Int J Clin Oncol 18:955–961

    Article  CAS  PubMed  Google Scholar 

  8. Dachman AH, Parker RL, Ros PR et al (1987) Hepatoblastoma: radiologic-pathologic correlation in 50 cases. Radiology 164:15–19

    Article  CAS  PubMed  Google Scholar 

  9. Bernard EJ, Nicholls W, Howman-Giles R et al (1997) Tl-201 positive, Ga-67 negative hepatoblastoma: a case report of a 12-year old boy. Clin Nucl Med 22:835–837

    Article  CAS  PubMed  Google Scholar 

  10. Cory DA, Siddiqui AR, Cohen MD (1987) Uptake of technetium 99m MDP by hepatoblastoma. Eur J Nucl Med 12:546–547

    Article  CAS  PubMed  Google Scholar 

  11. Archer D, Babyn P, Gilday D et al (1993) Potentially misleading bone scan findings in patients with hepatoblastoma. Clin Nucl Med 18:1026–1031

    Article  CAS  PubMed  Google Scholar 

  12. Phillip I, Shun A, McCowage G et al (2005) Positron emission tomography in recurrent hepatoblastoma. Pediatr Surg Int 21:341–345

    Article  Google Scholar 

  13. Sironi S, Messa C, Cistaro A et al (2004) Recurrent hepatoblastoma in orthotopic transplanted liver: detection with FDG positron emission tomography. AJR Am J Roentgenol 182:1214–1216

    Article  CAS  PubMed  Google Scholar 

  14. Mody RJ, Pohlem JA, Malde S et al (2006) FDG PET for the study of primary hepatic malignancies in children. Pediatr Blood Cancer 47:51–55

    Article  PubMed  Google Scholar 

  15. Cistaro A, Treglia G, Pagano M et al (2013) A comparison between 18F-FDG PET/CT imaging and biological and radiological restaging of hepatoblastoma patients. Biomed Res Int 2013:709037

    Article  PubMed Central  PubMed  Google Scholar 

  16. Wong KK, Lan LC, Lin SC et al (2004) The use of positron emission tomography in detecting hepatoblastoma recurrence—a cautionary tale. J Pediatr Surg 39:1779–1781

    Article  PubMed  Google Scholar 

  17. Bieze M, van Gulik TM, Bennink RJ (2013) Hepatoblastoma evaluated by 18F-fluoromethyl choline PET/CT. Clin Nucl Med 38:e80–e82

    Article  PubMed  Google Scholar 

  18. Kairemo KJ, Lindahl H, Merenmies J et al (2002) Anti-alpha-fetoprotein is useful for staging hepatoblastoma. Transplantation 73:1151–1154

    Article  PubMed  Google Scholar 

  19. Jordan AH, Pappo A (2012) Management of desmoplastic small round-cell tumors in children and young adults. J Pediatr Hematol Oncol 34(Suppl 2):S73–S75

    Article  PubMed  Google Scholar 

  20. Hayes-Jordan A, Anderson PM (2011) The diagnosis and management of desmoplastic round cell tumor: a review. Curr Opin Oncol 23:385–389

    Article  PubMed  Google Scholar 

  21. Chang F (2006) Desmoplastic small round cell tumors: cytologic, histologic, and immunohistochemical features. Arch Pathol Lab Med 130:728–732

    PubMed  Google Scholar 

  22. Gerald WL, Ladanyi M, de Alava E et al (1998) Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13, q12): desmoplastic small round cell tumor and its variants. J Clin Oncol 16:3028–3036

    CAS  PubMed  Google Scholar 

  23. Yagoob N, Hasan SH (2006) Desmoplastic small round cell tumor. J Coll Physicians Surg Pak 16:614–616

    Google Scholar 

  24. Subbiah V, Murthy R, Anderson PM (2011) [90Y]yttrium microspheres radioembolotherapy in desmoplastic small round cell tumor hepatic metastases. J Clin Oncol 29:e292–e294

    Article  PubMed Central  PubMed  Google Scholar 

  25. Iyer RS, Schauanaman G, Pruthi S et al (2013) Imaging of pediatric desmoplastic small-round cell tumor with pathologic correlation. Curr Probl Diagn Radiol 42:26–32

    Article  PubMed  Google Scholar 

  26. Zhang WD, Li CX, Liu QY et al (2011) CT, MRI, and FDG PET/CT imaging findings of abdominopelvic desmoplastic small round cell tumors: correlation with histopathologic findings. Eur J Radiol 80:269–273

    Article  PubMed  Google Scholar 

  27. Arora VC, Price AP, Fleming S et al (2013) Characteristic imaging features of desmoplastic small round cell tumor. Pediatr Radiol 43:93–102

    Article  PubMed  Google Scholar 

  28. Magnan H, Abramson SJ, Price AP et al (2013) J Pediatr Hematol Oncol 35:e190–e193

    Article  PubMed  Google Scholar 

  29. Dimitrakopoulou-Strauss A, Hohenberger P, Strobel P et al (2007) A recent application of fluoro-deoxyglucose positron emission tomography, treatment monitoring with a mammalian target of rapamycin inhibitor: an example of a patient with a desmoplastic small round cell tumor. Hell J Nucl Med 10:77–79

    PubMed  Google Scholar 

  30. Badalian-Very G, Vergilio JA, Fleming M et al (2013) Pathogenesis of Langerhans cell histiocytosis. Annu Rev Pathol 8:1–20

    Article  CAS  PubMed  Google Scholar 

  31. Ladisch S (1998) Langerhans cell histiocytosis. Curr Opin Hematol 5:54–58

    Article  CAS  PubMed  Google Scholar 

  32. Satter EK, High WA (2008) Langerhans cell histiocytosis: a review of the current recommendation of the Histiocyte Society. Pediatr Dermatol 25:291–295

    Article  PubMed  Google Scholar 

  33. Histiocytosis Association. http://www.histio.org/lchinchildren#.VA5GiuerwRx. Accessed 8 Sept 2014

  34. Donadieu J, Chalard F, Jeziorski E (2012) Medical management of Langerhans cell histiocytosis from diagnosis to treatment. Expert Opin Pharmacother 13:1309–1322

    Article  CAS  PubMed  Google Scholar 

  35. Minkov M (2011) Multisystem Langerhans cell histiocytosis in children: current treatment and future directions. Paediatr Drugs 13:75–86

    Article  PubMed  Google Scholar 

  36. Allen CE, McClain KL (2007) Langerhans cell histiocytosis: a review of past, current and future therapies. Drugs Today (Barc) 43:627–643

    Article  CAS  Google Scholar 

  37. Azouz EM, Saigal G, Rodriguez MM et al (2005) Langerhans’ cell histiocytosis: pathology, imaging and treatment of skeletal involvement. Pediatr Radiol 35:103–115

    Article  PubMed  Google Scholar 

  38. Van Nieuwenhuyse JP, Clapuyt P, Malghem J et al (1996) Radiographic skeletal survey and radionuclide bone scan in Langerhans cell histiocytosis of bone. Pediatr Radiol 26:734–738

    Article  PubMed  Google Scholar 

  39. Schaub T, Ash JM, Gilday DL (1987) Radionuclide imaging in histiocytosis X. Pediatr Radiol 17:397–404

    Article  CAS  PubMed  Google Scholar 

  40. Howarth DM, Mullan BP, Wiseman GA et al (1996) Bone scintigraphy in diagnosing and staging Langerhans’ cell histiocytosis and related disorders. J Nucl Med 37:1456–1460

    CAS  PubMed  Google Scholar 

  41. Parker BR, Pinckney L, Etcubanas E (1980) Relative efficacy of radiographic and radionuclide bone surveys in the detection of the skeletal lesions of histiocytosis X. Radiology 134:377–380

    Article  CAS  PubMed  Google Scholar 

  42. Goo HW, Yang DH, Ra YS et al (2006) Whole-body MRI of Langerhans cell histiocytosis: comparison with radiography and bone scintigraphy. Pediatr Radiol 36:1019–1031

    Article  PubMed  Google Scholar 

  43. Lastoria S, Montella L, Catalano L et al (2002) Functional imaging of Langerhans cell histiocytosis (111)In-DTPA-D-Phe(1)-octreotide scintigraphy. Cancer 94:633–640

    Article  PubMed  Google Scholar 

  44. Weinmann P, Crestani B, Tazi A et al (2000) 111In-pentetreotide scintigraphy in patients with Langerhans’ cell histiocytosis. J Nucl Med 41:1808–1812

    CAS  PubMed  Google Scholar 

  45. Lee HJ, Ahn BC, Lee SW et al (2012) The usefulness of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with Langerhans cell histiocytosis. Ann Nucl Med 26:730–737

    Article  PubMed  Google Scholar 

  46. Szturz P, Rehak Z, Koukalova R et al (2012) Measuring diffuse metabolic activity on FDG PET/CT: new method for evaluating Langerhans cell histiocytosis activity in pulmonary parenchyma. Nucl Med Biol 39:429–436

    Article  CAS  PubMed  Google Scholar 

  47. Krajicek BJ, Ryu JH, Hartman TE et al (2009) Abnormal fluorodeoxglucose PET in pulmonary Langerhans cell histiocytosis. Chest 135:1542–1549

    Article  PubMed  Google Scholar 

  48. Phillips M, Allen C, Gerson P et al (2009) Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis. Pediatr Blood Cancer 52:97–101

    Article  PubMed  Google Scholar 

  49. Buchler T, Cervinek L, Belohlavek O et al (2005) Langerhans cell histiocytosis with central nervous system involvement: follow-up by FDG-PET during treatment with cladribine. Pediatr Blood Cancer 44:286–288

    Article  PubMed  Google Scholar 

  50. Kaste SC, Rodriguez-Galindo C, McCarville ME et al (2007) PET-CT in pediatric Langerhans cell histiocytosis. Pediatr Radiol 37(7):615–622

    Article  PubMed  Google Scholar 

  51. Mueller WP, Melzer HI, Schmid I et al (2013) The diagnostic value of 18F-FDG PET and MRI in pediatric histiocytosis. Eur J Nucl Med Mol Imaging 40:356–363

    Article  PubMed  Google Scholar 

  52. Wajchenberg BL, Albergaria Pereira MA et al (2000) Adrenocortical carcinoma: clinical and laboratory observations. Cancer 88:711–736

    Article  CAS  PubMed  Google Scholar 

  53. Roman S et al (2006) Adrenocortical carcinoma. Curr Opin Oncol 18:36–42

    Article  PubMed  Google Scholar 

  54. Dackiw AP, Lee JE, Gagel RF et al (2001) Adrenal cortical carcinoma. World J Surg 25:914–926

    Article  CAS  PubMed  Google Scholar 

  55. Rodriguez-Galindo C, Figueiredo BC, Zambetti GP et al (2005) Biology, clinical characteristics, and management of adrenocortical tumors in children. Pediatr Blood Cancer 45(3):265–273

    Article  PubMed  Google Scholar 

  56. Ribeiro J, Ribeiro RC, Fletcher BD (2000) Imaging findings in pediatric and adrenocortical carcinoma. Pediatr Radiol 30:45–51

    Article  CAS  PubMed  Google Scholar 

  57. Binkovitz I, Henwood M, Caniano D et al (2008) Early detection of recurrent pediatric adrenal cortical carcinoma using FDG PET. Clin Nucl Med 33:186–188

    Article  PubMed  Google Scholar 

  58. Mackie GC, Shulkin BL, Ribeiro RC et al (2006) Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma. J Clin Endocrinol Metab 91:2665–2671

    Article  CAS  PubMed  Google Scholar 

  59. Becherer A, Vierhapper H, Potzi C et al (2001) FDG-PET in adrenocortical carcinoma. Cancer Biother Radiopharm 16:289–295

    Article  CAS  PubMed  Google Scholar 

  60. Gust L, Taieb D, Beliard A et al (2012) Preoperative 18F-FDG uptake is strongly correlated with malignancy, Weiss score, and molecular markers of aggressiveness in adrenal cortical tumors. World J Surg 36:1406–1410

    Article  PubMed  Google Scholar 

  61. Leboulleux S, Dromain C, Bonniaud G et al (2006) Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography. J Clin Endocrinol Metabol 91:920–925

    Article  CAS  Google Scholar 

  62. Leboulleux S, Deandreis D, Escourrou C et al (2011) Fluorodeoxyglucose uptake in the remaining adrenal glands during the follow-up of patients with adrenocortical carcinoma: do not consider it as malignancy. Eur J Endocrinol 164:89–94

    Article  CAS  PubMed  Google Scholar 

  63. Tessonnier L, Ansquer C, Bournaud C et al (2013) (18)F-FDG uptake at initial staging of the adrenocortical cancers: a diagnostic tool but not of prognostic value. World J Surg 37:107–112

    Article  CAS  PubMed  Google Scholar 

  64. Bergstrom M, Juhlin C, Bonasera TA et al (2000) PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate. J Nucl Med 41:252–282

    Google Scholar 

  65. Hahner S, Sundin A (2011) Metomidate-based imaging of adrenal masses. Horm Cancer 2:348–353

    Article  CAS  PubMed  Google Scholar 

  66. Kreissl MC, Schirbel A, Fassnacht M et al (2013) [123]iodometomidate imaging in adrenocortical carcinoma. J Clin Endocrinol Metab 98:2755–2764

    Article  CAS  PubMed  Google Scholar 

  67. Ohrvall U, Backlin K, Juhlin C et al (1995) Scintigraphy and biodistribution of monoclonal adrenocortical antibody in mice grafted with human adrenocortical carcinoma. Surgery 118:893–900

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

National Cancer Institute, National Institutes of Health, grant R01-CA111613 (H. Jadvar)

Author information

Authors and Affiliations

  1. Department of Radiology, Keck School of Medicine of USC, University of Southern California, 2250 Alcazar Street, CSC 102, Los Angeles, CA, 90033, USA

    Hossein Jadvar MD, PhD, MPH, MBA

  2. Department of Radiological Sciences, St. Jude Children’s Research Hospital, Memphis, TN, USA

    Barry L. Shulkin MD, MBA

Authors
  1. Hossein Jadvar MD, PhD, MPH, MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barry L. Shulkin MD, MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hossein Jadvar MD, PhD, MPH, MBA .

Editor information

Editors and Affiliations

  1. Nuclear Medicine, Second University of Naples, Napoli, Italy

    Luigi Mansi

  2. Nuclear Medicine, Humanitas Research Hospital, Rozzano, Milano, Italy

    Egesta Lopci

  3. Nuclear Medicine, Second University of Naples, Napoli, Italy

    Vincenzo Cuccurullo

  4. Nuclear Medicine, Humanitas Research Hospital, Rozzano, Milano, Italy

    Arturo Chiti

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Jadvar, H., Shulkin, B.L. (2016). Other Neoplasms. In: Mansi, L., Lopci, E., Cuccurullo, V., Chiti, A. (eds) Clinical Nuclear Medicine in Pediatrics. Springer, Cham. https://doi.org/10.1007/978-3-319-21371-2_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-21371-2_17

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-21370-5

  • Online ISBN: 978-3-319-21371-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation